Medical Device News Magazine

atHeart Medical

atHeart Medical Aims to Evolve Septal Closure with the reSept™ ASD Occluder: Commences Operations

Company has commenced operations and is initiating its U.S. Investigational Device Exemption (IDE) trial.
- Advertisement -spot_img

Latest News

RetiSpec Closes $10M USD to Advance Commercialization of its AI-Driven Eye Test for Detection of Alzheimer’s Disease

This funding will enable RetiSpec to accelerate the commercialization of its groundbreaking technology aimed at early detection of Alzheimer's disease.
- Advertisement -spot_img